Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to 1.09%.

  • Cross Country Healthcare's EBITDA Margin fell 27500.0% to 1.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.4%, marking a year-over-year decrease of 12800.0%. This contributed to the annual value of 1.09% for FY2024, which is 46800.0% down from last year.
  • Per Cross Country Healthcare's latest filing, its EBITDA Margin stood at 1.09% for FY2024, which was down 46800.0% from 3.6% recorded in FY2023.
  • In the past 5 years, Cross Country Healthcare's EBITDA Margin ranged from a high of 7.87% in FY2021 and a low of 1.55% during FY2020
  • Its 5-year average for EBITDA Margin is 3.09%, with a median of 3.6% in 2023.
  • In the last 5 years, Cross Country Healthcare's EBITDA Margin surged by 94300bps in 2021 and then plummeted by -46800bps in 2024.
  • Over the past 5 years, Cross Country Healthcare's EBITDA Margin (Annual) stood at 1.55% in 2020, then skyrocketed by 606bps to 7.87% in 2021, then dropped by -16bps to 6.63% in 2022, then crashed by -46bps to 3.6% in 2023, then crashed by -130bps to 1.09% in 2024.
  • Its last three reported values are 1.09% in FY2024, 3.6% for FY2023, and 6.63% during FY2022.